Abrisqueta, P., Loscertales, J., Terol, M. J., Ramírez Payer, Á., Ortiz, M., Pérez, I., . . . Villanueva, M. (2021). Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Citação norma ChicagoAbrisqueta, Pau, Javier Loscertales, María José Terol, Ángel Ramírez Payer, Macarena Ortiz, Inmaculada Pérez, Eduardo Ríos Herranz, y Miguel Villanueva. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). 2021.
Citação norma MLAAbrisqueta, Pau, et al. Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study). 2021.